secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cellectar Biosciences, Inc. (CLRB)
CIK:        0001279704
Form:       8-K
Filed at:   2023-08-21T23:59:59+00:00
Accession:  0001104659-23-093947
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Cellectar Biosciences receives Nasdaq delisting notice over negative stockholders' equity
--------------------------------------------------------------------------------

- Stockholders' equity of ($467,004) as of June 30, 2023, below Nasdaq's $2.5M minimum.
- Company has until September 30, 2023 to submit a compliance plan to Nasdaq.
- If plan accepted, extension possible until February 12, 2024; delisting risk remains.
- No immediate impact on listing; hearing process available if delisting determined.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1279704/000110465923093947/0001104659-23-093947-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1279704/000110465923093947/tm2324235d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-093947

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer